Wide Ranks

CODX

Co-Diagnostics, Inc.

0.9363

Top Statistics
Market Cap 29 M Forward PE -0.8003 Revenue Growth -73.90 %
Current Ratio 6.92 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.1400 Enterprise / Revenue -0.7370 Price To Sales Trailing12 Months 4.08
Profitability
Profit Margins 0.00 % Operating Margins -1596.36 %
Balance Sheet
Total Cash 37 M Total Cash Per Share 1.18 Total Debt 2 M
Total Debt To Equity 3.71 Current Ratio 6.92 Book Value Per Share 2.00
All Measures
Short Ratio 284.00 % Message Board Id finmb_60358987 Shares Short Prior Month 226426
Return On Equity -0.5057 City Salt Lake City Uuid a66500d7-07e3-3cc2-8d0a-703f2a3c6952
Previous Close 0.9300 First Trade Date Epoch Utc 1 B Book Value 2.00
Beta -0.8460 Total Debt 2 M Volume 272735
Price To Book 0.4686 Fifty Two Week Low 0.8800 Total Cash Per Share 1.18
Total Revenue 7 M Shares Short Previous Month Date 1 B Target Median Price 1.50
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -1596.36 %
Target Mean Price 1.50 Net Income To Common -41284272 Short Percent Of Float 0.0076
Implied Shares Outstanding 31 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 196560 Average Volume10days 196560 Total Cash 37 M
Next Fiscal Year End 1 B Revenue Per Share 0.2440 Held Percent Insiders 0.0670
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 0.9300 Target Low Price 1.50 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.19 Open 0.9200 Free Cashflow -12792538
State UT Dividend Yield 0.00 % Return On Assets -0.2761
Time Zone Short Name EST Trailing Eps -1.38 Day Low 0.8800
Address1 2401 South Foothill Drive Shares Outstanding 31 M Price Hint 4
Target High Price 1.50 Website https://www.codiagnostics.com 52 Week Change -0.2068
Average Volume 122135 Forward Eps -1.17 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 652.60 % Is_sp_500 False
Regular Market Day High 0.9816 Profit Margins 0.00 % Debt To Equity 3.71
Fifty Two Week High 2.23 Day High 0.9816 Shares Short 229088
Regular Market Open 0.9200 Industry Key medical-devices Earnings Growth 0.00 %
Enterprise To Revenue -0.7370 Revenue Growth -73.90 % Shares Percent Shares Out 0.0072
Operating Cashflow -25702664 Currency USD Time Zone Full Name America/New_York
Market Cap 29 M Is_nasdaq_100 False Zip 84109
Quote Type EQUITY Industry Medical Devices Long Name Co-Diagnostics, Inc.
Regular Market Day Low 0.8800 Held Percent Institutions 0.1396 Current Price 0.9363
Address2 Suite D Enterprise To Ebitda 0.1400 Financial Currency USD
Current Ratio 6.92 Gross Margins 49.30 % Industry Disp Medical Devices
Number Of Analyst Opinions 1 Country United States Float Shares 30 M
Two Hundred Day Average 1.22 Enterprise Value -5397529 Price To Sales Trailing12 Months 4.08
Forward PE -0.8003 Regular Market Volume 272735 Ebitda -38666460
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.

It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus.

In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings.

The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.